• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Antibiotic kills bacteria that causes Lyme disease

IThinkImTurningJapanese

Senior Member
Messages
3,492
Location
Japan
Antibiotic kills bacteria that causes Lyme disease

For decades, the routine treatment for Lyme disease has been standard antibiotics, which usually kill off the infection. But for up to 20% of people with the tick-borne illness, the antibiotics don’t work, and lingering symptoms of muscle pain, fatigue, and cognitive impairment can continue for years—sometimes indefinitely.

The new findings suggest the drug azlocillin not only kills off the disease-causing bacteria Borrelia burgdorferi at the onset of the illness, but could also effectively for treating patients infected with drug-tolerant bacteria that may cause lingering symptoms.

“This compound is just amazing,” says Jayakumar Rajadas, assistant professor of medicine and director of the Biomaterials and Advanced Drug Delivery Laboratory at the Stanford University School of Medicine and senior author of the paper, which appears in Scientific Reports. “It clears the infection without a lot of side effects.”

“We are hoping to repurpose it as an oral treatment for Lyme disease. We have been screening potential drugs for six years,” says lead author Venkata Raveendra Pothineni, a PhD working with Rajadas.

“We’ve screened almost 8,000 chemical compounds. We have tested 50 molecules in the dish. The most effective and safest molecules were tested in animal models. Along the way, I’ve met many people suffering with this horrible, lingering disease. Our main goal is to find the best compound for treating patients and stop this disease.”
 

valentinelynx

Senior Member
Messages
1,310
Location
Tucson
What a promising article! How refreshing to learn of a clinical scientist studying borrelia who hasn't adopted the nay-saying politics of IDSA. Dr. Rajadas understands the importance of persister cells in borrelia infection, hallelujah! Furthermore, testing has included animal models (poor mice); it is not just in vitro like so many drugs that have been held out as promising in the past.
 

shannah

Senior Member
Messages
1,429
Because of the blurred lines between Lyme and ME, I wonder if this might have implications for some in the ME community. Since Stanford is involved with this research, would it be worthwhile for Ron Davis to touch base with this team do you think @Janet Dafoe (Rose49) ?

"The new findings suggest the drug azlocillin not only kills off the disease-causing bacteria Borrelia burgdorferi at the onset of the illness, but could also effectively for treating patients infected with drug-tolerant bacteria that may cause lingering symptoms.

“This compound is just amazing,” says Jayakumar Rajadas, assistant professor of medicine and director of the Biomaterials and Advanced Drug Delivery Laboratory at the Stanford University School of Medicine and senior author of the paper, which appears in Scientific Reports. “It clears the infection without a lot of side effects.”


Antibiotic kills bacteria that causes Lyme disease
 

Hip

Senior Member
Messages
18,071
The study says:
So far, azlocillin is the FDA approved drug shown that killed both B. burgdorferi log phase and stationary phase cultures completely.

However, in spite of azlocillin being FDA approved, I cannot find it for sale in any pharmacy.
 
Back